Cosmetic Compliance
Intelligence & Solutions
FAQs regarding the Approval Standards of Quasi-drugs
Local Title:
医薬部外品の承認基準等の取扱いに関する質疑応答集(Q&A) について
Country/Region:
Japan
Status:
In force
Type:
FAQ
Release Date:
2021-06-28
Implementation Date:
2021-06-28
Competent Authority:
Ministry of Health, Labour and Welfare
Document:
Summary

On June 28, 2021, Japan MHLW updated the FAQs about the Approval for Quasi-drugs, which replaced the previous FAQs and came into effect on the date of promulgation. The updated FAQs clarifies the marketing/manufacturing approval of quasi-drugs, testing, quasi-drugs standards, etc. It includes 75 questions, among which Q47, Q48, Q53, Q54, Q74 and Q75 were newly-added questions.

Document
Original Language
Log in to access the document
LOG IN
Not a member yet? Sign up here.
History
FAQs regarding the Approval Standards of Quasi-drugs
Date of Release: 2021-06-28
Date of Implementation : 2021-06-28
Status : In force
FAQs regarding the Approval Standards of Quasi-drugs
Date of Release: 2016-03-25
Date of Implementation : 2016-03-25
Status : Invalid